A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold by targeting a protein required for the survival of the virus. The newly created molecule (IMP-1088) resides inside a protein in cells called N-myristoyltransferase (NMT). After invading the body, virus uses NMT to construct a shell for protecting their genomes, allowing them to replicate easily. Inhibiting the NMT with the molecule IMP-1088 restricted the growth and functioning of multiple strains of cold virus. According to the reports IMP-1088 has successfully blocked common cold virus without affecting the healthy cells. Team is planning to take IMP-1088 into animal trials to ensure that it is safe and does not target other conditions with different causes. Also, the team is now working on the drug delivery method via the lungs.